Literature DB >> 16226092

The QT and Tp-e intervals in left and right chest leads: comparison between patients with systemic and pulmonary hypertension.

Thinn Hlaing1, Donglin Guo, Xiaojing Zhao, Tara DiMino, Lee Greenspon, Peter R Kowey, Gan-Xin Yan.   

Abstract

BACKGROUND: Action potential duration in the right ventricle is normally shorter than that in the left. We tested the hypothesis that there may be intrinsic differences in the QT and Tp-e (an interval from the peak to the end of the T wave) intervals between the left and right chest leads that can be exaggerated by systemic hypertension but attenuated by pulmonary hypertension in humans.
METHODS: Electrocardiograms in the left (V4L-V6L) and right (V4R-V6R) chest leads were obtained in 40 healthy individuals, 29 patients with systemic hypertension and left ventricular hypertrophy, and 15 patients with pulmonary hypertension.
RESULTS: In healthy individuals, the corrected QT (QTc) and corrected Tp-e [T(p-e)c] intervals were 421+/-5 and 86+/-3 milliseconds in V4L through V6L, respectively, significantly longer than those recorded from V4R through V6R (383+/-5 and 62+/-4 milliseconds, respectively; P<.01). Left ventricular hypertrophy prolonged the QTc interval in V4L through V6L (456+/-5 milliseconds), exaggerating the difference in the QTc interval between the left and right chest leads (61+/-4 vs 40+/-3 milliseconds in healthy control subjects; P<.01). Left ventricular hypertrophy also resulted in a small but significant increase in the T(p-e)c interval in V4L through V6L (97+/-3 vs 86+/-3 milliseconds in control subjects; P<.05) but exerted no significant effect on the T(p-e)c interval in the right. In contrast, pulmonary hypertension lengthened the QTc interval in the right chest leads, reducing the difference in the QTc interval between the left and right chest leads (3+/-8 vs 40+/-3 milliseconds in control subjects; P<.01).
CONCLUSIONS: There are intrinsic differences in the QT and Tp-e intervals between V4L-V6L and V4R-V6R that are significantly amplified by systemic hypertension but markedly attenuated by pulmonary hypertension.

Entities:  

Mesh:

Year:  2005        PMID: 16226092     DOI: 10.1016/j.jelectrocard.2005.06.028

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  15 in total

1.  Cardiac arrhythmia mechanisms in rats with heart failure induced by pulmonary hypertension.

Authors:  David Benoist; Rachel Stones; Mark J Drinkhill; Alan P Benson; Zhaokang Yang; Cecile Cassan; Stephen H Gilbert; David A Saint; Olivier Cazorla; Derek S Steele; Olivier Bernus; Ed White
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

2.  Spontaneous ventricular fibrillation in right ventricular failure secondary to chronic pulmonary hypertension.

Authors:  Soban Umar; Jong-Hwan Lee; Enno de Lange; Andrea Iorga; Rod Partow-Navid; Aneesh Bapat; Arnoud van der Laarse; Rajeev Saggar; Rajan Saggar; Dirk L Ypey; Hrayr S Karagueuzian; Mansoureh Eghbali
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-12-22

Review 3.  Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure.

Authors:  Lin Piao; Glenn Marsboom; Stephen L Archer
Journal:  J Mol Med (Berl)       Date:  2010-09-04       Impact factor: 4.599

4.  Arrhythmogenic substrate in hearts of rats with monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.

Authors:  David Benoist; Rachel Stones; Mark Drinkhill; Olivier Bernus; Ed White
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-03-11       Impact factor: 4.733

5.  The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle.

Authors:  Lin Piao; Yong-Hu Fang; Virgilio J J Cadete; Christian Wietholt; Dalia Urboniene; Peter T Toth; Glenn Marsboom; Hannah J Zhang; Idith Haber; Jalees Rehman; Gary D Lopaschuk; Stephen L Archer
Journal:  J Mol Med (Berl)       Date:  2009-12-01       Impact factor: 4.599

6.  The relationship between systolic pulmonary arterial pressure and Tp-e interval, Tp-e/QT, and Tp-e/QTc ratios in patients with newly diagnosed chronic obstructive pulmonary disease.

Authors:  Ayhan Cosgun; Huseyin Oren; Mustafa Hamidullah Turkkani
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-09-11       Impact factor: 1.468

7.  Electrocardiographic findings in patients with polycythemia vera.

Authors:  Mehmet Kayrak; Kadir Acar; Enes Elvin Gul; Turyan Abdulhalikov; Murat Bağlıcaklıoğlu; Osman Sonmez; Zeynettin Kaya; Hatem Arı
Journal:  Int J Med Sci       Date:  2011-12-14       Impact factor: 3.738

8.  The Association between Myocardial Iron Load and Ventricular Repolarization Parameters in Asymptomatic Beta-Thalassemia Patients.

Authors:  Mehmet Kayrak; Kadir Acar; Enes Elvin Gul; Orhan Ozbek; Turyan Abdulhalikov; Osman Sonmez; Hajrudin Alibaşiç
Journal:  Adv Hematol       Date:  2012-05-15

9.  A step forward parameter for the effects of transcatheter aortic valve implantation: transmural dispersion of repolarization.

Authors:  Mehmet Tezcan; Ömer Yiğiner; Mehmet Doğan; Gökhan Değirmencioğlu
Journal:  J Geriatr Cardiol       Date:  2015-05       Impact factor: 3.327

10.  Left ventricular hypertrophy amplifies the QT, and Tp-e intervals and the Tp-e/ QT ratio of left chest ECG.

Authors:  Zhao Zhao; Zuyi Yuan; Yuqiang Ji; Yue Wu; Yinzhi Qi
Journal:  J Biomed Res       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.